Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (Rezafungin For Injection) For the Treatment of Candidemia and Invasive Candidiasis Posted on March 22, 2023July 10, 2023 by fraziermwd
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc. Posted on January 11, 2023July 25, 2023 by fraziermwd
Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform Posted on December 15, 2022July 10, 2023 by fraziermwd
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer Posted on December 14, 2022July 10, 2023 by fraziermwd
NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Posted on November 23, 2022July 10, 2023 by fraziermwd
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares Posted on October 13, 2022July 10, 2023 by fraziermwd
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock Posted on October 4, 2022July 10, 2023 by fraziermwd
Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics Posted on September 28, 2022July 10, 2023 by fraziermwd
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock Posted on September 19, 2022July 10, 2023 by fraziermwd
